The “regulatory affairs” section comprises over 200 tasks that need to be completed during the development and approval of medical devices.

Here, you will find an overview of the most essential content so that you can get your device approved quickly.

Regulatory Affairs und Zulassung

Content

On this page, you will find articles on the following topics:

  1. What regulatory affairs is
  2. Regulatory requirements
  3. Authorization and documentation
  4. Authorities, institutions, and associations
  5. Further topics of regulatory affairs

1. What regulatory affairs is

Regulatory affairs comprises the processes and activities that ensure that medical devices meet the regulatory requirements of the countries where they are sold. This includes

  • obtaining the necessary approvals from the regulatory authorities,
  • compliance with applicable regulations and standards, and
  • maintaining conformity throughout the entire product life cycle until decommissioning.

The tasks of regulatory affairs also include monitoring changes to regulations and standards and communicating these changes to stakeholders within the company to ensure continuous compliance.

Regulatory affairs thus plays a crucial role in ensuring that medical devices are safe, effective, and comply with legal requirements.

Further information

Refer also to the article on regulatory affairs managers’ tasks, competencies, and earning potential. This includes the task of developing a regulatory strategy.

2. Regulatory requirements

a) Germany

Laws Medical Devices Law (no longer valid)

Medical Devices Implementation Act MPDG

National regulations Medical Device Operator Ordinance (Medizinprodukte-Betreiberverordnung – MPBetreibV)

Medical Device User Notification and Information Ordinance (Medizinprodukte-Anwendermelde- und Informationsverordnung – MPAMIV)

b) Europe

EU directives (only for existing devices) Medical Device Directive (MDD, 93/42/EEC) and its essential requirements

In-vitro Diagnostic Directive (IVD, 98/79/EC)

Radio Equipment Directive RED

EU regulations Medical Device Regulation MDR

In-Vitro Diagnostics Regulation (IVDR)

General Data Protection Regulation (GDPR)

AI Regulation (planned)

PFAS Regulation (planned)

EU Battery Regulation

EU Data Act

EU AI Act

EU guidelines Overview of MDCG documents

Examples

Harmonized standards Overview of harmonized standards. You will find further articles on specific standards and their implementation (also) in these categories:

c) USA

Laws Food, Drug & Cosmetic Act (FD&C)

Administrative Laws (21 CFR)

General information Request for Information: How the FDA helps with classification

FDA eCopy Program

FDA Warning Letters and FDA Form 483 (Form 483)

FDA Inspection

Software Change: What the FDA expects from you

FDA MAUDE Database: Input for risk management

Approval procedure FDA updates “Refuse to Accept Policy” for 510(k)

The FDA Pre-Submission Program

The FDA Software Precertification (Pre-Cert) Pilot Program

FDA’s De Novo Program

Level of Concern: What the FDA wants to achieve with this program

Special 510(k): When the FDA will allow this “shortcut”

Breakthrough Devices Program of the FDA

Requirements FDA Human Factors Guidances

The FDA QSIT: Quality System Inspection Technique

The FDA Benefit-Risk Guidance

Recognized Consensus Standards of the FDA

Guidance ‘Interoperable Medical Devices’

Cybersecurity: FDA guidance documents

Complete overview

d) Other markets

see section 3.a)

3. Approval and documentation

a) Approval

Approval of medical devices (overview) Please also note the presentation describing the path to the CE mark as well as the articles “7 steps to a medical device” and “Approval of IVDs.
Conformity assessment procedure (assessing conformity with statutory requirements)
Approval in China
Approval China FDA / NMPA
Approval in Brazil
Approval in Japan
Approval Saudi Arabia (SFDA)
Approval South Korea

Find more information on international approval

b) Qualification and classification (How should my device be classified?)

Qualification as a medical device (medical device yes/no). This also includes the distinction between medicinal products and medical devices, as well as the special case of combination products.
Classification according to MDR Class I, IIa, IIb, III or IVDR Class A, B, C and D
Qualification and classification of software as a medical device
Classification of devices as accessories

c) Technical documentation (What do I need to document for each device?)

Technical documentation (overview)
Intended purpose (the foundation document)
Instructions for use
Clinical evaluation of medical devices according to MEDDEV 2.7/1 rev. 4
Risk management files: risk policy, risk management plan, risk analysis, risk management report
Usability file
Software file, e.g., software requirements specification, software architecture, software tests, software release. Please also note the special features of medical apps (mobile medical apps).
Verification and validation of medical devices
Unique Device Identification

d) Quality management (What should your company fulfill?)

Quality management is not usually the responsibility of regulatory affairs. Nevertheless, we have listed some important articles for you.

Steps to a certified QM system
Audits (especially of quality management systems)
Systems for Post-Market Surveillance and PMCF (Post-Market Clinical Follow-up) and vigilance

4. Authorities, institutions, and associations

a) Germany

Federal Institute for Drugs and Medical Devices (BfArM – Bundesamt für Arzneimittel und Medizinprodukte)
German Institute for Medical Informatics (DIMDI – Deutsches Institut für medizinische Informatik); has since been integrated into the BfArM
DAkkS, the German accreditation body
State authorities: Regional councils, trade supervisory offices, governments

b) Europe

Notified bodies
NBOG: Notified Body Operations Group
MDCG: Medical Device Coordination Group

c) International

IMDRF: International Medical Device Regulators Forum

5. Regulatory affairs: Further topics

Here, you will find an article on the tasks and competencies of regulatory affairs managers.

Note the advantages and disadvantages of Regulatory Information Management Systems (RIMS) and their role in manufacturers’ digital transformation.

Part of the tasks of regulatory affairs is regulatory intelligence.

Do you still have questions, for example, about the approval of your devices? Then, take advantage of our free micro-consulting service.

If you would like support in developing and “approving” your medical devices in compliance with the law, contact us right away. The Johner Institute team will be happy to help!


Post-Market Surveillance and monitoring of devices on the market

Post-Market Surveillance (PMS) is a proactive and systematic process to derive necessary corrective and preventive actions (CAPA) from information about medical devices already placed on the market. We have created a Post-Market Surveillance checklist for you. With this checklist, you can find out whether you meet the regulatory requirements of the MDR for Post-Market Surveillance…

Details

Distributor requirements (that also affect the manufacturers)

The medical device regulations have significantly increased the requirements for distributors. You need to understand these requirements to avoid multi-year custodial sentences threatened in the event of infringement. This article also considers extensive guidance issued by the Irish regulator. 1. What a “distributor” is (and what it isn’t) a) Definition The Medical Device Regulation (MDR) has many…

Details

Labeling for medical devices

Both European and U.S. regulations place requirements on the labeling. However, the two legal systems do not understand the term entirely identically. Even the spelling differs: labeling in the USA, labelling in Europe. In this article, you will learn what you need to keep in mind in each case when it comes to labeling. Speaking…

Details

Substance-based medical devices: What you need to do now in order to continue marketing your legacy device under the MDR

  Manufacturers of substance-based medical devices such as seawater nasal sprays, mucous membrane-soothing cough syrups, or osmotically active laxatives face several challenges once the Regulation (EU) 2017/745 (MDR) came into force: This article illustrates what can be done to overcome the regulatory hurdles and ensure the marketability of your substance-based medical devices beyond the transition…

Details

Planning sample sizes for clinical studies of medical devices and IVDs: The 6 questions your statistician must answer

If you have to conduct a clinical investigation for your medical device or clinical performance study for your IVD, you won’t be able to avoid sample size planning. And you will need to avoid the following two problems when calculating the sample size: Therefore, you need to accurately identify the exact sample size needed so…

Details